EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (Form S-8 to be filed on or about August 8, 2008) pertaining to the Halozyme Therapeutics, Inc. 2008 Outside Directors’ Stock Plan and the Halozyme Therapeutics, Inc. 2008 Stock Plan, of our reports dated March 12, 2008, with respect to the consolidated financial statements of Halozyme Therapeutics, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2007 and the effectiveness of internal control over financial reporting of Halozyme Therapeutics, Inc., filed with the Securities and Exchange Commission.
| /s/ Ernst & Young LLP | ||||
San Diego, California
August 4, 2008
August 4, 2008